The benefits of deploying WinNonlin® within your drug development enterprise include:
WinNonlin’s spreadsheet-like workbooks and wizard interfaces facilitate data management, analysis and generation of report-ready output. WinNonlin can automatically determine initial estimates for most library models.
WinNonlin, and its predecessors PCNonlin and Nonlin84, have been an industry standard for more than 20 years. See also WinNonlin® Validation Suite™ for details about WinNonlin software development and validation.
Within sessions, WinNonlin remembers links between input data, analysis settings and results, so output can be updated to reflect changes to the data or settings. Similarly, analyses stored through WinNonlin Enterprise into the Pharsight® Knowledgebase Server™ (PKS™) retain links from input to output, to take advantage of WinNonlin’s Refresh feature.
WinNonlin's scripting language accelerates routine analyses by automating repetitive tasks. Further, organizations using WinNonlin Enterprise with PKS can request custom automation tools to automate the entire process of data loading and analysis.
WinNonlin produces report-quality plots, tables and text output, ready to be pasted into a report or exported directly to Microsoft Word®. WinNonlin can export output to Word automatically at completion of modeling, or export selected objects in a batch at the user's command.
WinNonlin Enterprise is integrated with PKS and PKS Reporter, to automatically draw the latest WinNonlin results from PKS into standardized reports in Microsoft Word.
WinNonlin Enterprise communicates directly with PKS to load and save study data, analysis settings and results, as well as third-party files associated with a study. Similarly, WinNonlin Enterprise can draw data directly from any open database connectivity (ODBC) compliant database, such as Oracle or SAS, and save results directly to a table in that database.
WinNonlin Enterprise supports your best practices, within a department and across sites, with add-on capabilities to automate standard analyses and reports, through WinNonlin AutoPilot™ and PKS Reporter™.
Pharsight believes that deployment of a comprehensive and accessible PK/PD research knowledge management system will provide a foundation for a more rational and cost-effective drug development process, both improving scientific productivity and reducing information management overhead.
"SAS and all other SAS Institute Inc. product or service names are registered trademarks or trademarks of SAS Institute Inc. in the USA and other countries. ®indicates USA registration."